Literature DB >> 10832063

Manganese-porphyrin reactions with lipids and lipoproteins.

A Bloodsworth1, V B O'Donnell, I Batinic-Haberle, P H Chumley, J B Hurt, B J Day, J P Crow, B A Freeman.   

Abstract

Manganese porphyrin complexes serve to catalytically scavenge superoxide, hydrogen peroxide, and peroxynitrite. Herein, reactions of manganese 5,10,15,20-tetrakis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP(5+)) with lipids and lipid hydroperoxides (LOOH) are examined. In linoleic acid and human low-density lipoprotein (LDL), MnTE-2-PyP(5+) promotes oxidative reactions when biological reductants are not present. By redox cycling between Mn(+3) and Mn(+4) forms, MnTE-2-PyP(5+) initiates lipid peroxidation via decomposition of 13(S)hydroperoxyoctadecadienoic acid [13(S)HPODE], with a second-order rate constant of 8.9 x 10(3) M(-1)s(-1)and k(cat) = 0.32 s(-1). Studies of LDL oxidation demonstrate that: (i) MnTE-2-PyP(5+) can directly oxidize LDL, (ii) MnTE-2-PyP(5+) does not inhibit Cu-induced LDL oxidation, and (iii) MnTE-2-PyP(5+) plus a reductant partially inhibit lipid peroxidation. MnTE-2-PyP(5+) (1-5 microM) also significantly inhibits FeCl(3) plus ascorbate-induced lipid peroxidation of rat brain homogenate. In summary, MnTE-2-PyP(5+) initiates membrane lipid and lipoprotein oxidation in the absence of biological reductants, while MnTE-2-PyP(5+) inhibits lipid oxidation reactions initiated by other oxidants when reductants are present. It is proposed that, as the Mn(+3) resting redox state of MnTE-2-PyP(5+) becomes oxidized to the Mn(+4) redox state, LOOH is decomposed to byproducts that propagate lipid oxidation reactions. When the manganese of MnTE-2-PyP(5+) is reduced to the +2 state by biological reductants, antioxidant reactions of the metalloporphyrin are favored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832063     DOI: 10.1016/s0891-5849(00)00194-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease.

Authors:  Agnė Žiniauskaitė; Symantas Ragauskas; Anita K Ghosh; Rubina Thapa; Anne E Roessler; Peter Koulen; Giedrius Kalesnykas; Jenni J Hakkarainen; Simon Kaja
Journal:  Ocul Surf       Date:  2019-02-23       Impact factor: 5.033

Review 2.  A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Ludmil Benov
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

3.  Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment.

Authors:  Y Zhao; S Miriyala; L Miao; M Mitov; D Schnell; S K Dhar; J Cai; J B Klein; R Sultana; D A Butterfield; M Vore; I Batinic-Haberle; S Bondada; D K St Clair
Journal:  Free Radic Biol Med       Date:  2014-03-12       Impact factor: 7.376

4.  Opposite effects of Mn(III) and Fe(III) forms of meso-tetrakis(4-N-methyl pyridiniumyl) porphyrins on isolated rat liver mitochondria.

Authors:  M F Nepomuceno; M Tabak; A E Vercesi
Journal:  J Bioenerg Biomembr       Date:  2002-02       Impact factor: 2.945

5.  Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.

Authors:  Artak G Tovmasyan; Zrinka Rajic; Ivan Spasojevic; Julio S Reboucas; Xin Chen; Daniela Salvemini; Huaxin Sheng; David S Warner; Ludmil Benov; Ines Batinic-Haberle
Journal:  Dalton Trans       Date:  2011-03-08       Impact factor: 4.390

6.  Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.

Authors:  Zahid N Rabbani; Ines Batinic-Haberle; Mitchell S Anscher; Jie Huang; Brian J Day; Elaine Alexander; Mark W Dewhirst; Zeljko Vujaskovic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

7.  Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth.

Authors:  Steven S Giles; Ines Batinic-Haberle; John R Perfect; Gary M Cox
Journal:  Eukaryot Cell       Date:  2005-01

Review 8.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

9.  Late administration of Mn porphyrin-based SOD mimic enhances diabetic complications.

Authors:  Dana K Ali; Mabayoje Oriowo; Artak Tovmasyan; Ines Batinic-Haberle; Ludmil Benov
Journal:  Redox Biol       Date:  2013-09-20       Impact factor: 11.799

Review 10.  An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Redox Biol       Date:  2015-02-07       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.